Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00992953 · ClinicalTrials.gov registry record · Phase 1
Virtual Reality (VR) Therapy for Post-Traumatic Stress Disorder (PTSD)
A Phase 1 study of Post Traumatic Stress Disorder, sponsored by Office of Naval Research (ONR).
- Completed
- Registry status
- Phase 1
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT00992953: Completed Phase 1 study of Post Traumatic Stress Disorder, sponsored by Office of Naval Research (ONR).
NCT00992953 is a Phase 1 study of Post Traumatic Stress Disorder that has completed, run by Office of Naval Research (ONR). The registered enrollment target is 136 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00992953, a Phase 1 study of Post Traumatic Stress Disorder, has completed, sponsored by Office of Naval Research (ONR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
It is proposed that using Virtual Reality as part of therapy will result in improvements in Post Traumatic Stress Disorder for Service Members with PTSD related to service in Iraq and/or Afghanistan.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Virtual Reality Exposure with Stimulus Control
Study Locations (2)
California
- Naval Hosptial Camp Pendleton - Camp Pendlton
- Naval Medical Center San Diego (NMCSD) - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
What the finished NCT00992953 record still lists
NCT00992953 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT00992953 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00992953 about?
NCT00992953 is a clinical study titled "Virtual Reality (VR) Therapy for Post-Traumatic Stress Disorder (PTSD)". It is proposed that using Virtual Reality as part of therapy will result in improvements in Post Traumatic Stress Disorder for Service Members with PTSD related to service in Iraq and/or Afghanistan.
What is the current status of trial NCT00992953?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 136 participants. The study started on 2005-01. Estimated completion is 2009-10.
What conditions does trial NCT00992953 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT00992953?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Virtual Reality Exposure with Stimulus Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT00992953?
This trial is sponsored by Office of Naval Research (ONR), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00992953 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00992953's enrollment target sits among peer trials
136 85th of 262 higher than 177 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
RECRUITING · Phase 1
-
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
RECRUITING · Phase 1
-
Mitigating PTSD-CUD After Sexual Assault
RECRUITING · Phase 1
-
A Study of Psilocybin for PTSD
ACTIVE NOT RECRUITING · Phase 1
-
Biological Signatures, Probiotic Among Those With mTBI and PTSD
COMPLETED · Phase 1
-
Cannabidiol as a Treatment for AUD Comorbid With PTSD
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia